Nikhil Bharat Agrawal
About Nikhil Bharat Agrawal
Data last updated:
Nikhil Bharat Agrawal was a Director at Bonds Brain Technologies Private Limited (2024), Director at Medtrail Technologies Private Limited (2017–2022) and Director at Medtrail Labs Private Limited (2020–2022), and held 1 more directorship. The companies operate in BFSI and Healthcare.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Bonds Brain Technologies Private Limited U66309DL2024PTC427552 | Director | 29 Feb 2024 | 2024 | Active | |
 Medtrail Technologies Private Limited U74999DL2017PTC323701 | Director | 14 Sep 2017 | 2017 | ₹7.1 Lakh (FY 2024) | Active |
| Medtrail Labs Private Limited U74999DL2020PTC363485 | Director | 29 Apr 2020 | 2020 | ₹69.4 Lakh (FY 2021) | Active |
| Medtrail Procurement Services Private Limited U51909DL2020PTC363604 | Director | 07 May 2020 | 2020 | ₹74,315 (FY 2023) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nikhil Bharat Agrawal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nikhil Bharat Agrawal
Nikhil Bharat Agrawal was first appointed on 14 Sep 2017 as Director at Medtrail Technologies Private Limited. The most recent appointment on record is 29 Feb 2024 at Bonds Brain Technologies Private Limited.
Nikhil Bharat Agrawal held 4 earlier board appointments: Bonds Brain Technologies Private Limited (Director, 29 Feb 2024 to 25 Oct 2024); Medtrail Technologies Private Limited (Director, 14 Sep 2017 to 15 Apr 2022); Medtrail Labs Private Limited (Director, 29 Apr 2020 to 15 Apr 2022); Medtrail Procurement Services Private Limited (Director, 07 May 2020 to 15 Apr 2022).